2[2]Habel LA,VanDenEeden SK,Sherman KJ,et al.Risk factors for incident and recurrent condylomata acuminata among women.A population based study[J].Sex Transm Dis,1998,25(6):285-292.
4[4]Van Den Eeden SK,Habel LA,Sherman KJ,et al.Risk factors for incident and recurrent condylomata acuminata among men.A population based study[J].Sex Transm Dis,1998,25(6):278-284.
8[4]Habel LA,Van Den Eenden SK,Sherman KJ,et al.Risk factors for incident and recurrent congdylomata acuminata among women.A population-based study[J].Sex Transm Dis,1998,25 (6):285-292.
9[5]Van Den Eenden SK,Habel LA,Sherman K J,et al.Risk factors for incident and recurrent congdylomata acuminata among men.A population-based study[J].Sex Transm Dis,1998,25 (6):278-284.
10[6]Munk C,Svare El,Poll P,et al.History of genital warts in 10,838 women 20 to 29 years of age from the generalpopulation.Risk factors and association with Papanicolaou smear history[J].Sex Transm Dis,1997,24 (10):567-572.
1HABEL L A, VANDEN EDEN S K, SHERMAN K J, et al. Riskfactors for incident and recurrent condylomata acuminate amongwomen. A population based study [J]. Sex Transm Dis, 1998,25(6): 285 -292.
2GEORGALA S, KATOULIS A C,GEORG ALA C,et al. Oralisotretinoin in the treatment of recalcitrant condylomata acuminataof the cervix : A randomised placebo controlledtrial [ J ]. SexTransm Infect, 2004 , 80(3) : 216 -218.
3HOYME U B, HAGEDOM M,SCHINDLE A E, et al. Effect ofadjuvant imquimod 5 % cream on sustained eleareanee of angenitalwaits following laser treatment [ J ]. Infect Dis Obstet Gyneeol,2002,10(2) : 79-88.
4AHMED A M, MADKAN V, TYRING S K. Human papillomavirusesand genital disease [J]. Dermatol Clin, 2006 , 24(2) : 157 -165.
5ARIAS DIAZ J,HDEFONSO J A, MUNOZ J J, et al. Tacrolimusand sirolimus decrease Thl/Th2 ratio, and increase regulatory Tlymphocytes in the liver after ischemia/reperfusion [ J] . T,ah In-vest, 2009, 89(4) : 433 -445.
6Cauda R, Tying SK, Grossi CE, et al. Patients with Condyloma acumina- tum exhibit decreased interleulin-2 and interferon gamma production and depressed natural killer activity [ J ]. J Clin Immunol, 1987,7 ( 4 ) : 304 - 307.
7Habel LA, VanDenEeden SK, Sherman K J, et al. Risk factors for in- cident and recurrent condylomata acuminate among women. A popula- tion based study[ J]. Sex Transm Dis, 1998,25 ( 6 ) :285 - 292.
8Fuente SG, Ludwig KA, Mantyh CR. Preoperative immune status de- termines anal condyloma relapse after surgical excision [ J ]. Dis Colon Rectum ,2003,46 ( 3 ) :367 - 373.
9Gcorgala S, Katoulis AC, Georgala C, et al. Oral isotretinoin in the treat- ment of recalcitrant condylomata acuminata of the cervix : A randomised placebo controlledtrial [ J ]. Sex Transm Infect,2004,80 ( 3 ) :216 - 218.
10Hoyme UB, Hagedom M, Schindle AE, et al. Effect of adjuvant imquimod 5 % cream on sustained eleareanee of angenital warts following laser treatment[ J]. Infect Dis Obstet Gyneeol,2002,10 ( 2 ) :79 - 88.
